nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—ABCG2—Sulfasalazine—Crohn's disease	0.147	0.685	CbGbCtD
Mitoxantrone—ABCB1—Prednisone—Crohn's disease	0.0423	0.197	CbGbCtD
Mitoxantrone—Blood creatinine abnormal—Mesalazine—Crohn's disease	0.0337	0.081	CcSEcCtD
Mitoxantrone—CYP3A4—Prednisone—Crohn's disease	0.0254	0.118	CbGbCtD
Mitoxantrone—Urine color abnormal—Mesalazine—Crohn's disease	0.0119	0.0286	CcSEcCtD
Mitoxantrone—Myelosuppression—Mercaptopurine—Crohn's disease	0.011	0.0265	CcSEcCtD
Mitoxantrone—Infertility—Mesalazine—Crohn's disease	0.0108	0.0259	CcSEcCtD
Mitoxantrone—Non-Hodgkin's lymphoma—Azathioprine—Crohn's disease	0.00883	0.0212	CcSEcCtD
Mitoxantrone—SLC47A2—digestive system—Crohn's disease	0.00857	0.0919	CbGeAlD
Mitoxantrone—Chromaturia—Mesalazine—Crohn's disease	0.00787	0.0189	CcSEcCtD
Mitoxantrone—Bone marrow depression—Mercaptopurine—Crohn's disease	0.00767	0.0184	CcSEcCtD
Mitoxantrone—BTK—mammalian vulva—Crohn's disease	0.00737	0.079	CbGeAlD
Mitoxantrone—PIM1—skin of body—Crohn's disease	0.007	0.0751	CbGeAlD
Mitoxantrone—Myelosuppression—Azathioprine—Crohn's disease	0.00658	0.0158	CcSEcCtD
Mitoxantrone—BTK—lymphoid tissue—Crohn's disease	0.00654	0.0702	CbGeAlD
Mitoxantrone—Interstitial pneumonia—Azathioprine—Crohn's disease	0.00639	0.0153	CcSEcCtD
Mitoxantrone—PIM1—mammalian vulva—Crohn's disease	0.00638	0.0685	CbGeAlD
Mitoxantrone—Interstitial pneumonia—Mesalazine—Crohn's disease	0.00582	0.014	CcSEcCtD
Mitoxantrone—PIM1—lymphoid tissue—Crohn's disease	0.00567	0.0608	CbGeAlD
Mitoxantrone—PIM1—digestive system—Crohn's disease	0.0056	0.06	CbGeAlD
Mitoxantrone—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.00558	0.0134	CcSEcCtD
Mitoxantrone—Ulcer—Mercaptopurine—Crohn's disease	0.00548	0.0131	CcSEcCtD
Mitoxantrone—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.00528	0.0127	CcSEcCtD
Mitoxantrone—Local reaction—Mesalazine—Crohn's disease	0.00508	0.0122	CcSEcCtD
Mitoxantrone—Urine abnormality—Mesalazine—Crohn's disease	0.00508	0.0122	CcSEcCtD
Mitoxantrone—Nephropathy toxic—Mesalazine—Crohn's disease	0.0049	0.0118	CcSEcCtD
Mitoxantrone—Urine analysis abnormal—Mesalazine—Crohn's disease	0.00478	0.0115	CcSEcCtD
Mitoxantrone—Platelet count decreased—Mesalazine—Crohn's disease	0.00473	0.0113	CcSEcCtD
Mitoxantrone—TOP2A—Methyldopa—Mesalazine—Crohn's disease	0.00464	0.766	CbGdCrCtD
Mitoxantrone—Bone marrow depression—Azathioprine—Crohn's disease	0.00457	0.011	CcSEcCtD
Mitoxantrone—Sepsis—Mercaptopurine—Crohn's disease	0.0045	0.0108	CcSEcCtD
Mitoxantrone—Interstitial lung disease—Azathioprine—Crohn's disease	0.00436	0.0105	CcSEcCtD
Mitoxantrone—Bone marrow depression—Mesalazine—Crohn's disease	0.00417	0.01	CcSEcCtD
Mitoxantrone—Interstitial lung disease—Mesalazine—Crohn's disease	0.00397	0.00953	CcSEcCtD
Mitoxantrone—Blood potassium decreased—Prednisone—Crohn's disease	0.00391	0.00939	CcSEcCtD
Mitoxantrone—Menorrhagia—Mesalazine—Crohn's disease	0.0038	0.00912	CcSEcCtD
Mitoxantrone—TOP2A—mammalian vulva—Crohn's disease	0.00374	0.0402	CbGeAlD
Mitoxantrone—BTK—lymph node—Crohn's disease	0.00369	0.0396	CbGeAlD
Mitoxantrone—SLC47A1—mammalian vulva—Crohn's disease	0.00342	0.0367	CbGeAlD
Mitoxantrone—Gamma-glutamyltransferase increased—Mesalazine—Crohn's disease	0.00342	0.0082	CcSEcCtD
Mitoxantrone—Amenorrhoea—Mesalazine—Crohn's disease	0.0032	0.00768	CcSEcCtD
Mitoxantrone—Proteinuria—Mesalazine—Crohn's disease	0.0032	0.00768	CcSEcCtD
Mitoxantrone—PIM1—lymph node—Crohn's disease	0.0032	0.0343	CbGeAlD
Mitoxantrone—Protein urine present—Mesalazine—Crohn's disease	0.00316	0.00757	CcSEcCtD
Mitoxantrone—Pancytopenia—Mercaptopurine—Crohn's disease	0.00309	0.00741	CcSEcCtD
Mitoxantrone—Hypocalcaemia—Mesalazine—Crohn's disease	0.00307	0.00737	CcSEcCtD
Mitoxantrone—SLC47A1—digestive system—Crohn's disease	0.003	0.0322	CbGeAlD
Mitoxantrone—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.00297	0.00713	CcSEcCtD
Mitoxantrone—Blood bilirubin increased—Mesalazine—Crohn's disease	0.00297	0.00713	CcSEcCtD
Mitoxantrone—Stomatitis—Mercaptopurine—Crohn's disease	0.00282	0.00678	CcSEcCtD
Mitoxantrone—CYP1B1—smooth muscle tissue—Crohn's disease	0.00278	0.0299	CbGeAlD
Mitoxantrone—CYP1B1—skin of body—Crohn's disease	0.00275	0.0295	CbGeAlD
Mitoxantrone—Blood urea increased—Mesalazine—Crohn's disease	0.00265	0.00637	CcSEcCtD
Mitoxantrone—Ecchymosis—Mesalazine—Crohn's disease	0.00254	0.0061	CcSEcCtD
Mitoxantrone—Febrile neutropenia—Prednisone—Crohn's disease	0.00247	0.00594	CcSEcCtD
Mitoxantrone—Alopecia—Mercaptopurine—Crohn's disease	0.0023	0.00552	CcSEcCtD
Mitoxantrone—ABCC1—mammalian vulva—Crohn's disease	0.00225	0.0242	CbGeAlD
Mitoxantrone—CYP1B1—lymphoid tissue—Crohn's disease	0.00223	0.0239	CbGeAlD
Mitoxantrone—Renal failure acute—Mesalazine—Crohn's disease	0.00221	0.00531	CcSEcCtD
Mitoxantrone—CYP1B1—digestive system—Crohn's disease	0.0022	0.0236	CbGeAlD
Mitoxantrone—Anaemia—Mercaptopurine—Crohn's disease	0.00209	0.00502	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00204	0.0049	CcSEcCtD
Mitoxantrone—Leukopenia—Mercaptopurine—Crohn's disease	0.00203	0.00487	CcSEcCtD
Mitoxantrone—Arthralgia—Mercaptopurine—Crohn's disease	0.00193	0.00463	CcSEcCtD
Mitoxantrone—Fungal infection—Prednisone—Crohn's disease	0.00193	0.00462	CcSEcCtD
Mitoxantrone—Blood creatinine increased—Mesalazine—Crohn's disease	0.00191	0.00459	CcSEcCtD
Mitoxantrone—Necrosis—Prednisone—Crohn's disease	0.0019	0.00455	CcSEcCtD
Mitoxantrone—TOP2A—lymph node—Crohn's disease	0.00188	0.0201	CbGeAlD
Mitoxantrone—ABCG2—mammalian vulva—Crohn's disease	0.00187	0.02	CbGeAlD
Mitoxantrone—Abdominal pain upper—Mesalazine—Crohn's disease	0.00186	0.00447	CcSEcCtD
Mitoxantrone—Oedema—Mercaptopurine—Crohn's disease	0.00185	0.00444	CcSEcCtD
Mitoxantrone—Pancytopenia—Azathioprine—Crohn's disease	0.00184	0.00441	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00184	0.00441	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00181	0.00434	CcSEcCtD
Mitoxantrone—Petechiae—Prednisone—Crohn's disease	0.00181	0.00434	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.0018	0.00432	CcSEcCtD
Mitoxantrone—Skin disorder—Mercaptopurine—Crohn's disease	0.0018	0.00431	CcSEcCtD
Mitoxantrone—Anorexia—Mercaptopurine—Crohn's disease	0.00176	0.00423	CcSEcCtD
Mitoxantrone—Pneumonia—Azathioprine—Crohn's disease	0.00174	0.00417	CcSEcCtD
Mitoxantrone—SLC47A1—lymph node—Crohn's disease	0.00171	0.0184	CbGeAlD
Mitoxantrone—Contusion—Prednisone—Crohn's disease	0.00171	0.00409	CcSEcCtD
Mitoxantrone—Amenorrhoea—Prednisone—Crohn's disease	0.00169	0.00406	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00168	0.00404	CcSEcCtD
Mitoxantrone—Pancytopenia—Mesalazine—Crohn's disease	0.00168	0.00402	CcSEcCtD
Mitoxantrone—Neutropenia—Mesalazine—Crohn's disease	0.00165	0.00396	CcSEcCtD
Mitoxantrone—Viral infection—Prednisone—Crohn's disease	0.00165	0.00395	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00164	0.00394	CcSEcCtD
Mitoxantrone—Agranulocytosis—Azathioprine—Crohn's disease	0.00161	0.00387	CcSEcCtD
Mitoxantrone—Decreased appetite—Mercaptopurine—Crohn's disease	0.00161	0.00386	CcSEcCtD
Mitoxantrone—Weight increased—Mesalazine—Crohn's disease	0.00161	0.00385	CcSEcCtD
Mitoxantrone—Weight decreased—Mesalazine—Crohn's disease	0.0016	0.00383	CcSEcCtD
Mitoxantrone—Pneumonia—Mesalazine—Crohn's disease	0.00158	0.0038	CcSEcCtD
Mitoxantrone—Ulcer—Prednisone—Crohn's disease	0.00157	0.00377	CcSEcCtD
Mitoxantrone—Haemoglobin—Azathioprine—Crohn's disease	0.00156	0.00374	CcSEcCtD
Mitoxantrone—Haemorrhage—Azathioprine—Crohn's disease	0.00155	0.00372	CcSEcCtD
Mitoxantrone—Renal failure—Mesalazine—Crohn's disease	0.00155	0.00371	CcSEcCtD
Mitoxantrone—Stomatitis—Mesalazine—Crohn's disease	0.00153	0.00368	CcSEcCtD
Mitoxantrone—Jaundice—Mesalazine—Crohn's disease	0.00153	0.00368	CcSEcCtD
Mitoxantrone—Conjunctivitis—Mesalazine—Crohn's disease	0.00153	0.00367	CcSEcCtD
Mitoxantrone—Urinary tract infection—Mesalazine—Crohn's disease	0.00153	0.00367	CcSEcCtD
Mitoxantrone—Sweating—Mesalazine—Crohn's disease	0.00151	0.00362	CcSEcCtD
Mitoxantrone—Haematuria—Mesalazine—Crohn's disease	0.0015	0.0036	CcSEcCtD
Mitoxantrone—Sinusitis—Mesalazine—Crohn's disease	0.00148	0.00354	CcSEcCtD
Mitoxantrone—Agranulocytosis—Mesalazine—Crohn's disease	0.00147	0.00352	CcSEcCtD
Mitoxantrone—PIM1—C-MYB transcription factor network—PTGS2—Crohn's disease	0.00146	0.00543	CbGpPWpGaD
Mitoxantrone—Body temperature increased—Mercaptopurine—Crohn's disease	0.00146	0.00351	CcSEcCtD
Mitoxantrone—BTK—Activated TLR4 signalling—RIPK2—Crohn's disease	0.00144	0.00534	CbGpPWpGaD
Mitoxantrone—CYP2E1—lymphoid tissue—Crohn's disease	0.00143	0.0154	CbGeAlD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—SOCS1—Crohn's disease	0.00142	0.00529	CbGpPWpGaD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisone—Crohn's disease	0.00142	0.234	CbGdCrCtD
Mitoxantrone—Haemoglobin—Mesalazine—Crohn's disease	0.00142	0.00341	CcSEcCtD
Mitoxantrone—CYP2E1—digestive system—Crohn's disease	0.00142	0.0152	CbGeAlD
Mitoxantrone—Rhinitis—Mesalazine—Crohn's disease	0.00142	0.0034	CcSEcCtD
Mitoxantrone—Hepatitis—Mesalazine—Crohn's disease	0.00141	0.00339	CcSEcCtD
Mitoxantrone—Haemorrhage—Mesalazine—Crohn's disease	0.00141	0.00339	CcSEcCtD
Mitoxantrone—Pharyngitis—Mesalazine—Crohn's disease	0.0014	0.00336	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—ERAP2—Crohn's disease	0.0014	0.0052	CbGpPWpGaD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—UBE2D1—Crohn's disease	0.0014	0.00518	CbGpPWpGaD
Mitoxantrone—Chills—Azathioprine—Crohn's disease	0.00139	0.00334	CcSEcCtD
Mitoxantrone—Arrhythmia—Azathioprine—Crohn's disease	0.00138	0.00332	CcSEcCtD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00137	0.00508	CbGpPWpGaD
Mitoxantrone—Alopecia—Azathioprine—Crohn's disease	0.00137	0.00329	CcSEcCtD
Mitoxantrone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00136	0.00327	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—RIPK2—Crohn's disease	0.00135	0.00502	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.00135	0.005	CbGpPWpGaD
Mitoxantrone—Ecchymosis—Prednisone—Crohn's disease	0.00135	0.00323	CcSEcCtD
Mitoxantrone—BTK—TSLP Signaling Pathway—JAK2—Crohn's disease	0.00133	0.00495	CbGpPWpGaD
Mitoxantrone—BTK—Activated TLR4 signalling—TAB1—Crohn's disease	0.00133	0.00493	CbGpPWpGaD
Mitoxantrone—BTK—Activated TLR4 signalling—NOD2—Crohn's disease	0.0013	0.00484	CbGpPWpGaD
Mitoxantrone—Sepsis—Prednisone—Crohn's disease	0.00129	0.0031	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—IL12B—Crohn's disease	0.00128	0.00474	CbGpPWpGaD
Mitoxantrone—Chills—Mesalazine—Crohn's disease	0.00127	0.00304	CcSEcCtD
Mitoxantrone—Diarrhoea—Mercaptopurine—Crohn's disease	0.00126	0.00304	CcSEcCtD
Mitoxantrone—CYP1B1—lymph node—Crohn's disease	0.00126	0.0135	CbGeAlD
Mitoxantrone—Ill-defined disorder—Azathioprine—Crohn's disease	0.00125	0.00301	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—TAB1—Crohn's disease	0.00125	0.00463	CbGpPWpGaD
Mitoxantrone—Alopecia—Mesalazine—Crohn's disease	0.00125	0.00299	CcSEcCtD
Mitoxantrone—Anaemia—Azathioprine—Crohn's disease	0.00125	0.00299	CcSEcCtD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—UBE2D1—Crohn's disease	0.00124	0.00461	CbGpPWpGaD
Mitoxantrone—BTK—Activated TLR4 signalling—SOCS1—Crohn's disease	0.00123	0.00456	CbGpPWpGaD
Mitoxantrone—Erythema—Mesalazine—Crohn's disease	0.00123	0.00295	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—NOD2—Crohn's disease	0.00123	0.00455	CbGpPWpGaD
Mitoxantrone—Malaise—Azathioprine—Crohn's disease	0.00122	0.00292	CcSEcCtD
Mitoxantrone—BTK—TSLP Signaling Pathway—CXCL8—Crohn's disease	0.00122	0.00451	CbGpPWpGaD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00121	0.00449	CbGpPWpGaD
Mitoxantrone—Leukopenia—Azathioprine—Crohn's disease	0.00121	0.0029	CcSEcCtD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—RIPK2—Crohn's disease	0.00121	0.00447	CbGpPWpGaD
Mitoxantrone—Dysgeusia—Mesalazine—Crohn's disease	0.0012	0.00289	CcSEcCtD
Mitoxantrone—Cardiac failure congestive—Prednisone—Crohn's disease	0.00119	0.00286	CcSEcCtD
Mitoxantrone—CYP1B1—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.00119	0.00442	CbGpPWpGaD
Mitoxantrone—Back pain—Mesalazine—Crohn's disease	0.00119	0.00285	CcSEcCtD
Mitoxantrone—Vomiting—Mercaptopurine—Crohn's disease	0.00118	0.00282	CcSEcCtD
Mitoxantrone—Rash—Mercaptopurine—Crohn's disease	0.00117	0.0028	CcSEcCtD
Mitoxantrone—ABCC1—S1P1 pathway—PTGS2—Crohn's disease	0.00116	0.00432	CbGpPWpGaD
Mitoxantrone—Dermatitis—Mercaptopurine—Crohn's disease	0.00116	0.00279	CcSEcCtD
Mitoxantrone—Vision blurred—Mesalazine—Crohn's disease	0.00116	0.00278	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—SOCS1—Crohn's disease	0.00116	0.00429	CbGpPWpGaD
Mitoxantrone—Arthralgia—Azathioprine—Crohn's disease	0.00115	0.00276	CcSEcCtD
Mitoxantrone—Myalgia—Azathioprine—Crohn's disease	0.00115	0.00276	CcSEcCtD
Mitoxantrone—CYP3A4—digestive system—Crohn's disease	0.00114	0.0122	CbGeAlD
Mitoxantrone—Ill-defined disorder—Mesalazine—Crohn's disease	0.00114	0.00274	CcSEcCtD
Mitoxantrone—Anaemia—Mesalazine—Crohn's disease	0.00114	0.00273	CcSEcCtD
Mitoxantrone—Discomfort—Azathioprine—Crohn's disease	0.00114	0.00272	CcSEcCtD
Mitoxantrone—ABCC1—lymph node—Crohn's disease	0.00113	0.0121	CbGeAlD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—TAB1—Crohn's disease	0.00113	0.00417	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—MADCAM1—Crohn's disease	0.00112	0.00416	CbGpPWpGaD
Mitoxantrone—BTK—IL-5 Signaling Pathway—STAT3—Crohn's disease	0.00111	0.00413	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—TAB1—Crohn's disease	0.00111	0.00413	CbGpPWpGaD
Mitoxantrone—BTK—Kit receptor signaling pathway—JAK2—Crohn's disease	0.00111	0.00412	CbGpPWpGaD
Mitoxantrone—Malaise—Mesalazine—Crohn's disease	0.00111	0.00266	CcSEcCtD
Mitoxantrone—Cardiac failure—Prednisone—Crohn's disease	0.00111	0.00266	CcSEcCtD
Mitoxantrone—Leukopenia—Mesalazine—Crohn's disease	0.0011	0.00264	CcSEcCtD
Mitoxantrone—Nausea—Mercaptopurine—Crohn's disease	0.0011	0.00264	CcSEcCtD
Mitoxantrone—Infection—Azathioprine—Crohn's disease	0.00109	0.00263	CcSEcCtD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—NOD2—Crohn's disease	0.00109	0.00405	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00108	0.00401	CbGpPWpGaD
Mitoxantrone—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00108	0.00259	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Azathioprine—Crohn's disease	0.00108	0.00259	CcSEcCtD
Mitoxantrone—Cough—Mesalazine—Crohn's disease	0.00107	0.00257	CcSEcCtD
Mitoxantrone—Skin disorder—Azathioprine—Crohn's disease	0.00107	0.00257	CcSEcCtD
Mitoxantrone—Hypertension—Mesalazine—Crohn's disease	0.00106	0.00255	CcSEcCtD
Mitoxantrone—ABCB1—epithelium—Crohn's disease	0.00106	0.0114	CbGeAlD
Mitoxantrone—Chest pain—Mesalazine—Crohn's disease	0.00105	0.00251	CcSEcCtD
Mitoxantrone—Arthralgia—Mesalazine—Crohn's disease	0.00105	0.00251	CcSEcCtD
Mitoxantrone—Myalgia—Mesalazine—Crohn's disease	0.00105	0.00251	CcSEcCtD
Mitoxantrone—Anxiety—Mesalazine—Crohn's disease	0.00104	0.0025	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—SOCS1—Crohn's disease	0.00104	0.00387	CbGpPWpGaD
Mitoxantrone—Discomfort—Mesalazine—Crohn's disease	0.00103	0.00248	CcSEcCtD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—TLR4—Crohn's disease	0.00103	0.00382	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—SOCS1—Crohn's disease	0.00103	0.00382	CbGpPWpGaD
Mitoxantrone—Hypotension—Azathioprine—Crohn's disease	0.00103	0.00247	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—ICOSLG—Crohn's disease	0.00101	0.00376	CbGpPWpGaD
Mitoxantrone—Confusional state—Mesalazine—Crohn's disease	0.00101	0.00243	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.001	0.00241	CcSEcCtD
Mitoxantrone—Oedema—Mesalazine—Crohn's disease	0.001	0.00241	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Mesalazine—Crohn's disease	0.001	0.00241	CcSEcCtD
Mitoxantrone—Infection—Mesalazine—Crohn's disease	0.000997	0.00239	CcSEcCtD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000988	0.00367	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000988	0.00367	CbGpPWpGaD
Mitoxantrone—Shock—Mesalazine—Crohn's disease	0.000987	0.00237	CcSEcCtD
Mitoxantrone—Hypokalaemia—Prednisone—Crohn's disease	0.000983	0.00236	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Mesalazine—Crohn's disease	0.000982	0.00236	CcSEcCtD
Mitoxantrone—Tachycardia—Mesalazine—Crohn's disease	0.000979	0.00235	CcSEcCtD
Mitoxantrone—BTK—TSLP Signaling Pathway—STAT3—Crohn's disease	0.000978	0.00363	CbGpPWpGaD
Mitoxantrone—Skin disorder—Mesalazine—Crohn's disease	0.000974	0.00234	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Mesalazine—Crohn's disease	0.00097	0.00233	CcSEcCtD
Mitoxantrone—Anorexia—Mesalazine—Crohn's disease	0.000956	0.0023	CcSEcCtD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000955	0.00354	CbGpPWpGaD
Mitoxantrone—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000952	0.00229	CcSEcCtD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—RASGRP1—Crohn's disease	0.000948	0.00352	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—DEFA5—Crohn's disease	0.00094	0.00349	CbGpPWpGaD
Mitoxantrone—Hypotension—Mesalazine—Crohn's disease	0.000937	0.00225	CcSEcCtD
Mitoxantrone—ABCG2—lymph node—Crohn's disease	0.000935	0.01	CbGeAlD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—TAB1—Crohn's disease	0.000927	0.00344	CbGpPWpGaD
Mitoxantrone—ABCB1—mammalian vulva—Crohn's disease	0.000921	0.00987	CbGeAlD
Mitoxantrone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000914	0.00219	CcSEcCtD
Mitoxantrone—Sweating increased—Prednisone—Crohn's disease	0.000909	0.00218	CcSEcCtD
Mitoxantrone—Feeling abnormal—Azathioprine—Crohn's disease	0.000908	0.00218	CcSEcCtD
Mitoxantrone—Paraesthesia—Mesalazine—Crohn's disease	0.000901	0.00216	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000901	0.00216	CcSEcCtD
Mitoxantrone—Dyspnoea—Mesalazine—Crohn's disease	0.000894	0.00215	CcSEcCtD
Mitoxantrone—Somnolence—Mesalazine—Crohn's disease	0.000892	0.00214	CcSEcCtD
Mitoxantrone—BTK—Activated TLR4 signalling—TLR4—Crohn's disease	0.000889	0.0033	CbGpPWpGaD
Mitoxantrone—Dyspepsia—Mesalazine—Crohn's disease	0.000883	0.00212	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.00088	0.00327	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—RASGRP1—Crohn's disease	0.000877	0.00325	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—CD79A—Crohn's disease	0.000874	0.00324	CbGpPWpGaD
Mitoxantrone—Neutropenia—Prednisone—Crohn's disease	0.000873	0.00209	CcSEcCtD
Mitoxantrone—Decreased appetite—Mesalazine—Crohn's disease	0.000872	0.00209	CcSEcCtD
Mitoxantrone—Abdominal pain—Azathioprine—Crohn's disease	0.000871	0.00209	CcSEcCtD
Mitoxantrone—Body temperature increased—Azathioprine—Crohn's disease	0.000871	0.00209	CcSEcCtD
Mitoxantrone—Fatigue—Mesalazine—Crohn's disease	0.000865	0.00208	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Prednisone—Crohn's disease	0.00086	0.00206	CcSEcCtD
Mitoxantrone—Constipation—Mesalazine—Crohn's disease	0.000858	0.00206	CcSEcCtD
Mitoxantrone—Pain—Mesalazine—Crohn's disease	0.000858	0.00206	CcSEcCtD
Mitoxantrone—BTK—Immune System—ERAP2—Crohn's disease	0.00085	0.00315	CbGpPWpGaD
Mitoxantrone—Weight increased—Prednisone—Crohn's disease	0.000849	0.00204	CcSEcCtD
Mitoxantrone—Weight decreased—Prednisone—Crohn's disease	0.000844	0.00203	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Prednisone—Crohn's disease	0.000842	0.00202	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—TLR4—Crohn's disease	0.000836	0.0031	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Mesalazine—Crohn's disease	0.000827	0.00198	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Prednisone—Crohn's disease	0.00082	0.00197	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00082	0.00197	CcSEcCtD
Mitoxantrone—ABCB1—lymphoid tissue—Crohn's disease	0.000817	0.00877	CbGeAlD
Mitoxantrone—Myocardial infarction—Prednisone—Crohn's disease	0.000816	0.00196	CcSEcCtD
Mitoxantrone—BTK—Kit receptor signaling pathway—STAT3—Crohn's disease	0.000815	0.00303	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Azathioprine—Crohn's disease	0.000811	0.00195	CcSEcCtD
Mitoxantrone—ABCB1—digestive system—Crohn's disease	0.000807	0.00866	CbGeAlD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—TYK2—Crohn's disease	0.000802	0.00298	CbGpPWpGaD
Mitoxantrone—Urticaria—Mesalazine—Crohn's disease	0.000797	0.00191	CcSEcCtD
Mitoxantrone—Abdominal pain—Mesalazine—Crohn's disease	0.000793	0.0019	CcSEcCtD
Mitoxantrone—Body temperature increased—Mesalazine—Crohn's disease	0.000793	0.0019	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—CARD9—Crohn's disease	0.000766	0.00284	CbGpPWpGaD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—JAK2—Crohn's disease	0.000765	0.00284	CbGpPWpGaD
Mitoxantrone—Bradycardia—Prednisone—Crohn's disease	0.000761	0.00183	CcSEcCtD
Mitoxantrone—Diarrhoea—Azathioprine—Crohn's disease	0.000754	0.00181	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—TLR4—Crohn's disease	0.000753	0.00279	CbGpPWpGaD
Mitoxantrone—Haemoglobin—Prednisone—Crohn's disease	0.000751	0.0018	CcSEcCtD
Mitoxantrone—Haemorrhage—Prednisone—Crohn's disease	0.000747	0.00179	CcSEcCtD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—TLR4—Crohn's disease	0.000745	0.00276	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Mesalazine—Crohn's disease	0.000739	0.00177	CcSEcCtD
Mitoxantrone—Asthenia—Mesalazine—Crohn's disease	0.00072	0.00173	CcSEcCtD
Mitoxantrone—CYP1B1—Metapathway biotransformation—GPX4—Crohn's disease	0.000709	0.00263	CbGpPWpGaD
Mitoxantrone—Vomiting—Azathioprine—Crohn's disease	0.0007	0.00168	CcSEcCtD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000696	0.00258	CbGpPWpGaD
Mitoxantrone—Rash—Azathioprine—Crohn's disease	0.000694	0.00167	CcSEcCtD
Mitoxantrone—Dermatitis—Azathioprine—Crohn's disease	0.000694	0.00167	CcSEcCtD
Mitoxantrone—BTK—Activated TLR4 signalling—TYK2—Crohn's disease	0.000692	0.00257	CbGpPWpGaD
Mitoxantrone—Headache—Azathioprine—Crohn's disease	0.00069	0.00166	CcSEcCtD
Mitoxantrone—Diarrhoea—Mesalazine—Crohn's disease	0.000686	0.00165	CcSEcCtD
Mitoxantrone—BTK—TSLP Signaling Pathway—IL6—Crohn's disease	0.000683	0.00254	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MADCAM1—Crohn's disease	0.000679	0.00252	CbGpPWpGaD
Mitoxantrone—SLC47A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000677	0.00251	CbGpPWpGaD
Mitoxantrone—Arrhythmia—Prednisone—Crohn's disease	0.000667	0.0016	CcSEcCtD
Mitoxantrone—BTK—Activated TLR4 signalling—JAK2—Crohn's disease	0.000661	0.00245	CbGpPWpGaD
Mitoxantrone—Alopecia—Prednisone—Crohn's disease	0.00066	0.00158	CcSEcCtD
Mitoxantrone—Nausea—Azathioprine—Crohn's disease	0.000654	0.00157	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—TYK2—Crohn's disease	0.000651	0.00242	CbGpPWpGaD
Mitoxantrone—Erythema—Prednisone—Crohn's disease	0.00065	0.00156	CcSEcCtD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000646	0.0024	CbGpPWpGaD
Mitoxantrone—Vomiting—Mesalazine—Crohn's disease	0.000638	0.00153	CcSEcCtD
Mitoxantrone—Rash—Mesalazine—Crohn's disease	0.000633	0.00152	CcSEcCtD
Mitoxantrone—Dermatitis—Mesalazine—Crohn's disease	0.000632	0.00152	CcSEcCtD
Mitoxantrone—Headache—Mesalazine—Crohn's disease	0.000628	0.00151	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—JAK2—Crohn's disease	0.000621	0.00231	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000616	0.00228	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ICOSLG—Crohn's disease	0.000614	0.00228	CbGpPWpGaD
Mitoxantrone—Vision blurred—Prednisone—Crohn's disease	0.000613	0.00147	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Prednisone—Crohn's disease	0.000603	0.00145	CcSEcCtD
Mitoxantrone—Anaemia—Prednisone—Crohn's disease	0.000601	0.00144	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000599	0.00222	CbGpPWpGaD
Mitoxantrone—Nausea—Mesalazine—Crohn's disease	0.000596	0.00143	CcSEcCtD
Mitoxantrone—Malaise—Prednisone—Crohn's disease	0.000586	0.00141	CcSEcCtD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—TYK2—Crohn's disease	0.00058	0.00215	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000579	0.00215	CbGpPWpGaD
Mitoxantrone—Convulsion—Prednisone—Crohn's disease	0.000563	0.00135	CcSEcCtD
Mitoxantrone—Hypertension—Prednisone—Crohn's disease	0.000561	0.00135	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—NOD1—Crohn's disease	0.000559	0.00207	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000555	0.00206	CbGpPWpGaD
Mitoxantrone—Myalgia—Prednisone—Crohn's disease	0.000554	0.00133	CcSEcCtD
Mitoxantrone—Arthralgia—Prednisone—Crohn's disease	0.000554	0.00133	CcSEcCtD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—JAK2—Crohn's disease	0.000553	0.00205	CbGpPWpGaD
Mitoxantrone—Anxiety—Prednisone—Crohn's disease	0.000552	0.00132	CcSEcCtD
Mitoxantrone—BTK—Immune System—IFNGR2—Crohn's disease	0.000548	0.00203	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—DEFA5—Crohn's disease	0.000548	0.00203	CbGpPWpGaD
Mitoxantrone—Discomfort—Prednisone—Crohn's disease	0.000547	0.00131	CcSEcCtD
Mitoxantrone—ABCC1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000537	0.00199	CbGpPWpGaD
Mitoxantrone—Anaphylactic shock—Prednisone—Crohn's disease	0.000531	0.00127	CcSEcCtD
Mitoxantrone—Oedema—Prednisone—Crohn's disease	0.000531	0.00127	CcSEcCtD
Mitoxantrone—Infection—Prednisone—Crohn's disease	0.000527	0.00127	CcSEcCtD
Mitoxantrone—Shock—Prednisone—Crohn's disease	0.000522	0.00125	CcSEcCtD
Mitoxantrone—CYP1B1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.00052	0.00193	CbGpPWpGaD
Mitoxantrone—Tachycardia—Prednisone—Crohn's disease	0.000518	0.00124	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000517	0.00192	CbGpPWpGaD
Mitoxantrone—Skin disorder—Prednisone—Crohn's disease	0.000516	0.00124	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—TYK2—Crohn's disease	0.000514	0.00191	CbGpPWpGaD
Mitoxantrone—Hyperhidrosis—Prednisone—Crohn's disease	0.000513	0.00123	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—CXCL8—Crohn's disease	0.000511	0.0019	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CCR6—Crohn's disease	0.000508	0.00188	CbGpPWpGaD
Mitoxantrone—Anorexia—Prednisone—Crohn's disease	0.000506	0.00121	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—JAK2—Crohn's disease	0.00049	0.00182	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—IL1B—Crohn's disease	0.00049	0.00182	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000487	0.00181	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—TYK2—Crohn's disease	0.000484	0.00179	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—TYK2—Crohn's disease	0.000484	0.00179	CbGpPWpGaD
Mitoxantrone—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000484	0.00116	CcSEcCtD
Mitoxantrone—Paraesthesia—Prednisone—Crohn's disease	0.000477	0.00114	CcSEcCtD
Mitoxantrone—Dyspepsia—Prednisone—Crohn's disease	0.000467	0.00112	CcSEcCtD
Mitoxantrone—CYP2E1—Metapathway biotransformation—GPX4—Crohn's disease	0.000463	0.00172	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000462	0.00172	CbGpPWpGaD
Mitoxantrone—Decreased appetite—Prednisone—Crohn's disease	0.000461	0.00111	CcSEcCtD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—JAK2—Crohn's disease	0.000461	0.00171	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—JAK2—Crohn's disease	0.000461	0.00171	CbGpPWpGaD
Mitoxantrone—ABCB1—lymph node—Crohn's disease	0.000461	0.00495	CbGeAlD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00046	0.00171	CbGpPWpGaD
Mitoxantrone—Fatigue—Prednisone—Crohn's disease	0.000458	0.0011	CcSEcCtD
Mitoxantrone—Constipation—Prednisone—Crohn's disease	0.000454	0.00109	CcSEcCtD
Mitoxantrone—BTK—Immune System—CARD9—Crohn's disease	0.000446	0.00166	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000445	0.00165	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—RBX1—Crohn's disease	0.000441	0.00164	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Prednisone—Crohn's disease	0.000437	0.00105	CcSEcCtD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000436	0.00162	CbGpPWpGaD
Mitoxantrone—Gastrointestinal pain—Prednisone—Crohn's disease	0.000434	0.00104	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.00043	0.0016	CbGpPWpGaD
Mitoxantrone—Urticaria—Prednisone—Crohn's disease	0.000422	0.00101	CcSEcCtD
Mitoxantrone—Abdominal pain—Prednisone—Crohn's disease	0.00042	0.00101	CcSEcCtD
Mitoxantrone—Body temperature increased—Prednisone—Crohn's disease	0.00042	0.00101	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—UBE2D1—Crohn's disease	0.000403	0.00149	CbGpPWpGaD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—IL6—Crohn's disease	0.000392	0.00146	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000391	0.00145	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Prednisone—Crohn's disease	0.000391	0.000939	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—RIPK2—Crohn's disease	0.00039	0.00145	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—UBE2D1—Crohn's disease	0.000387	0.00143	CbGpPWpGaD
Mitoxantrone—Asthenia—Prednisone—Crohn's disease	0.000381	0.000914	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000378	0.0014	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000375	0.00139	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.000375	0.00139	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—RIPK2—Crohn's disease	0.000375	0.00139	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ITGA4—Crohn's disease	0.000375	0.00139	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000372	0.00138	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000372	0.00138	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—RASGRP1—Crohn's disease	0.000368	0.00137	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Prednisone—Crohn's disease	0.000363	0.000872	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—TAB1—Crohn's disease	0.00036	0.00134	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	0.000356	0.00132	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—NOD2—Crohn's disease	0.000354	0.00131	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—RASGRP1—Crohn's disease	0.000354	0.00131	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD79A—Crohn's disease	0.000352	0.00131	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000349	0.0013	CbGpPWpGaD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	0.000345	0.00128	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000344	0.00128	CbGpPWpGaD
Mitoxantrone—BTK—Activated TLR4 signalling—IL6—Crohn's disease	0.000339	0.00126	CbGpPWpGaD
Mitoxantrone—Vomiting—Prednisone—Crohn's disease	0.000337	0.00081	CcSEcCtD
Mitoxantrone—Rash—Prednisone—Crohn's disease	0.000335	0.000803	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisone—Crohn's disease	0.000334	0.000802	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—SOCS1—Crohn's disease	0.000334	0.00124	CbGpPWpGaD
Mitoxantrone—Headache—Prednisone—Crohn's disease	0.000333	0.000798	CcSEcCtD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000327	0.00121	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000327	0.00121	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NOD1—Crohn's disease	0.000326	0.00121	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—SOCS1—Crohn's disease	0.00032	0.00119	CbGpPWpGaD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—IL6—Crohn's disease	0.000319	0.00118	CbGpPWpGaD
Mitoxantrone—Nausea—Prednisone—Crohn's disease	0.000315	0.000757	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000314	0.00117	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	0.000307	0.00114	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000305	0.00113	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CCR6—Crohn's disease	0.000296	0.0011	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000295	0.00109	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	0.000287	0.00106	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000285	0.00106	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—IL6—Crohn's disease	0.000284	0.00105	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.00028	0.00104	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000276	0.00102	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—UBE2D1—Crohn's disease	0.000274	0.00102	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PTPN2—Crohn's disease	0.00027	0.001	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—RBX1—Crohn's disease	0.000267	0.000992	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000266	0.000986	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000262	0.000973	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CRP—Crohn's disease	0.000252	0.000933	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—IL6—Crohn's disease	0.000251	0.000933	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—TLR4—Crohn's disease	0.000241	0.000895	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	0.000237	0.000878	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—IL6—Crohn's disease	0.000237	0.000878	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—UBE2D1—Crohn's disease	0.000234	0.00087	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000232	0.00086	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000231	0.000856	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—RIPK2—Crohn's disease	0.000227	0.000844	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ITGA4—Crohn's disease	0.000227	0.000844	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ICAM1—Crohn's disease	0.000222	0.000824	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL3—Crohn's disease	0.000222	0.000823	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000222	0.000822	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000215	0.000797	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—RASGRP1—Crohn's disease	0.000214	0.000796	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RSPO3—Crohn's disease	0.000214	0.000794	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD79A—Crohn's disease	0.000214	0.000793	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TAB1—Crohn's disease	0.00021	0.000779	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NOD2—Crohn's disease	0.000206	0.000765	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PLA2G4F—Crohn's disease	0.000205	0.000761	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000204	0.000757	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SEL1L—Crohn's disease	0.000203	0.000752	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PLA2G4F—Crohn's disease	0.000198	0.000736	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000197	0.000732	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—SOCS1—Crohn's disease	0.000194	0.000721	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—TYK2—Crohn's disease	0.000188	0.000697	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000185	0.000686	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—LTF—Crohn's disease	0.000182	0.000675	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PLA2G4F—Crohn's disease	0.00018	0.000669	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000179	0.000665	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—JAK2—Crohn's disease	0.000179	0.000665	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000177	0.000657	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000177	0.000657	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL18—Crohn's disease	0.000175	0.000649	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTMR3—Crohn's disease	0.000174	0.000647	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000172	0.000638	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CD4—Crohn's disease	0.00017	0.000631	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTMR3—Crohn's disease	0.000169	0.000625	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.000165	0.000612	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD4—Crohn's disease	0.000163	0.000605	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL2RA—Crohn's disease	0.000155	0.000576	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTMR3—Crohn's disease	0.000153	0.000569	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GCKR—Crohn's disease	0.000147	0.000544	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CRP—Crohn's disease	0.000147	0.000544	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TLR4—Crohn's disease	0.00014	0.000521	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—IL6—Crohn's disease	0.000139	0.000515	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—FADS1—Crohn's disease	0.000136	0.000504	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ICAM1—Crohn's disease	0.000135	0.0005	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—FADS1—Crohn's disease	0.000131	0.000487	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SLC11A1—Crohn's disease	0.00013	0.000481	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	0.000129	0.00048	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GPX4—Crohn's disease	0.000127	0.000472	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000125	0.000463	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GPX4—Crohn's disease	0.000123	0.000456	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GCKR—Crohn's disease	0.000123	0.000456	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.00012	0.000444	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—FADS1—Crohn's disease	0.000119	0.000443	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GCKR—Crohn's disease	0.000119	0.000441	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GPX4—Crohn's disease	0.000112	0.000415	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HSPA1B—Crohn's disease	0.000111	0.000412	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RBX1—Crohn's disease	0.000111	0.000412	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00011	0.000409	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTMR3—Crohn's disease	0.00011	0.000409	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TYK2—Crohn's disease	0.000109	0.000406	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GCKR—Crohn's disease	0.000108	0.000401	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—JAK2—Crohn's disease	0.000104	0.000387	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IFNG—Crohn's disease	0.000102	0.00038	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD4—Crohn's disease	9.9e-05	0.000367	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLA2G4F—Crohn's disease	9.75e-05	0.000362	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—UBE2D1—Crohn's disease	9.74e-05	0.000362	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IL6—Crohn's disease	9.19e-05	0.000341	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL1B—Crohn's disease	9.14e-05	0.000339	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.77e-05	0.000326	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	8.75e-05	0.000325	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—FADS1—Crohn's disease	8.58e-05	0.000318	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.49e-05	0.000315	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	8.34e-05	0.00031	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTMR3—Crohn's disease	8.29e-05	0.000308	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GPX4—Crohn's disease	8.03e-05	0.000298	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GCKR—Crohn's disease	7.76e-05	0.000288	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.68e-05	0.000285	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—STAT3—Crohn's disease	7.66e-05	0.000284	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.42e-05	0.000276	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	7.34e-05	0.000272	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SMAD3—Crohn's disease	6.97e-05	0.000259	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—FADS1—Crohn's disease	6.46e-05	0.00024	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GPX4—Crohn's disease	6.05e-05	0.000224	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	6.01e-05	0.000223	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	5.9e-05	0.000219	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GCKR—Crohn's disease	5.84e-05	0.000217	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—Crohn's disease	5.35e-05	0.000199	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTMR3—Crohn's disease	5.11e-05	0.00019	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TYK2—Crohn's disease	4.55e-05	0.000169	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—JAK2—Crohn's disease	4.34e-05	0.000161	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD4—Crohn's disease	4.11e-05	0.000153	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—Crohn's disease	4.08e-05	0.000151	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—FADS1—Crohn's disease	3.98e-05	0.000148	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.97e-05	0.000147	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—Crohn's disease	3.91e-05	0.000145	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—Crohn's disease	3.78e-05	0.00014	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPX4—Crohn's disease	3.73e-05	0.000138	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GCKR—Crohn's disease	3.6e-05	0.000134	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—Crohn's disease	3.44e-05	0.000128	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—Crohn's disease	3.42e-05	0.000127	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—Crohn's disease	3.31e-05	0.000123	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—STAT3—Crohn's disease	3.18e-05	0.000118	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—Crohn's disease	3.01e-05	0.000112	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—Crohn's disease	2.47e-05	9.16e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—Crohn's disease	2.22e-05	8.25e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—Crohn's disease	2.16e-05	8.01e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—Crohn's disease	1.86e-05	6.9e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—Crohn's disease	1.63e-05	6.04e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—Crohn's disease	1.15e-05	4.25e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—Crohn's disease	1e-05	3.72e-05	CbGpPWpGaD
